MetLife Inc. (NYSE: MET) stock has achieved $72.12 in the past week

0
8

MetLife Inc. (NYSE:MET) saw an upside of 0.71% to close Monday at $70.69 after adding $0.5 on the day. The 5-day average trading volume is 4,458,940 shares of the company’s common stock. It has gained $72.12 in the past week and touched a new high 1 time within the past 5 days. An average of 3,352,780 shares of the company has been traded in the last 20 days, and the 50-day average volume stands at 3,723,092.

MET’s 1-month performance is -1.53% or -$1.58 on its low of $69.12 reached on 01/19/23. The company’s shares have touched a 52-week low of $57.41 and high of $77.36, with the stock’s rally to the 52-week high happening on 01/06/23. YTD, MET has lost -2.32% or -$1.68 and has reached a new high 3 times. However, the current price is down -8.62% from the 52-week high price.

Top 5 Undervalued Stocks To Own In 2023

Microchip Maker Releases "World's Most Powerful Data Center CPU". It could allow the company who manufactures it to lead the industry as the global microchip shortage continues into the coming year. We've put together a free research report that explains all the details. Not only will you find out why analysts believe this chip manufacturer could lead the pack, you will also discover four more potential winners for the coming year.

Click here to download your Free Research Report…

Sponsored

Insider Transactions

MET stock investors last saw insider trading activity on Dec 20.PODLOGAR SUSAN M (EVP & Chief HR Officer) most recently sold 3,000 shares at $71.91 per share on Dec 20. This transaction cost the insider $215,730. EVP & Chief Investment Officer, Goulart Steven J, sold 29,401 shares at a price of $71.88 on Dec 12. Then, on Dec 12, President & CEO Khalaf Michel sold 57,201 shares at a price of $72.49 per share. This transaction amounted to $4,146,638.

Valuation Metrics

MET stock has a beta of 1.09. Moving on to other valuation ratios, the trailing price-to-sales (P/S) ratio is 0.74 while the price-to-book (PB) in the most recent quarter is 2.24, with the price to cash flow ratio at 3.81.

As well, the company’s long term debt to equity for the quarter ending June 29 was 0.70, while the total debt to equity was 0.71. The firm’s gross profit as reported stood at $8.13 billion against revenue of $71.08 billion.

Earnings Surprise

For the quarterly period ending June 29 this year, Net income and sales went up compared to those figures reported in the previous quarter. Net income shrunk -359.52% to $331.0 million, while revenue of $103.0 million was 68.88% off the previous quarter. Analysts expected MET to announce $1.45 per share in earnings in its latest quarter, but it posted $2, representing a 37.90% surprise. EBITDA for the quarter stood at more than $419.0 million. Shareholders hold equity totaling $784.61 million.

Let’s look briefly at MetLife Inc. (MET) price momentum from a technical analysis perspective. The 9-day relative strength index as at close on 23 January was 43.16% to suggest the stock is trending Neutral, with historical volatility in this time period at 14.57%.

The stock’s 5-day moving average is $70.41, reflecting a -1.71% or -$1.23 change from its current price. MET is currently trading -2.95% above its 20-day SMA, +8.04% above its 100-day SMA. However, the stock’s current price level is away from the SMA50 by -3.71% and SMA200 by+0.97%.

Stochastic %K and %D was 20.49% and 14.51% and the average true range (ATR) pointed at 1.23. The RSI (14) points at 43.35%, while the 14-day stochastic is at 32.71% with the period’s ATR at 1.26. The stock’s 9-day MACD Oscillator is pointing at -0.84 and -1.42 on the 14-day charts.

Analyst Ratings

In the most recent analyst report for MetLife Inc. (NYSE: MET), Goldman downgraded it to a Neutral rating. They previously had a Buy rating on the stock. Analysts offering their rating for MET stock have a consensus rating for the stock as Overweight. Currently, 0 brokerage advisors rate MET as a “sell,”, while 5 advise that investors “Hold.” 0 analysts have rated the stock as underweight. 2 rates the stock as overweight while 12 have offered a “buy” rating.

What is MET’s price target for the next 12 months?

Analysts have a consensus price target ranging from a low of $78.00 and a high of $93.00, with their median price target at $83.00. Looking at these predictions, the average price target given by analysts is for MetLife Inc. (MET) stock is $83.31.

LEAVE A REPLY

Please enter your comment!
Please enter your name here